Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Los Angeles › NPI 1699752766
Lab

National Genetics Institute

National Genetics Institute was paid $1.08M by Medicaid between Jan 2018 and May 2022, across 3 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 97% of everything it billed.

33Billing provider infoNATIONAL GENETICS INSTITUTE
LOS ANGELES, CA 90064
33aNPI1699752766assigned 12/29/2005
28Total paid$1.08M
24GClaims23,777
24DCodes billed3
24AFirst – last monthJan 2018 – May 2022
Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#185 of 561
Median peer was paid$222K
This provider vs. median4.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Single-Code Concentration97% of spending on code U0003 with only 3 total codes billed. Highly concentrated billing profile.
Entity ProliferationAuthorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201884$1K
20202,679$108K
202117,397$771K
20223,617$197K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 97% 21,360 18,420 $1.04M
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 3.2% 2,333 2,109 $34K
87522 Neg quan hep c or qual rna <1% 84 77 $1K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWILLIAMS, KIMBERLY (VP)
Same official

Other billing entities under WILLIAMS, KIMBERLY

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.